Time New York: Thu 29 Sep 14:44 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Aldeyra Therapeutics (ALDX) Worth a Look: Stock Gains 7%

Zacks

Aldeyra Therapeutics, Inc. ALDX was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.37 to $7.35 in the past one-month time frame.

In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher can last.

Aldeyra Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

ALDEYRA THERAPT Price

ALDEYRA THERAPT Price | ALDEYRA THERAPT Quote


A better-ranked stock in the Med-Drugs industry is Corcept Therapeutics Incorporated CORT, with a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ALDX going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.